Comparison of cell deaths induced by transmembrane and secretory TNF-α

Abstract

Our previous study showed that transmembrane TNF-α (TM-TNF-α) had broader tumoricidal spectrum than secretory TNF-α (s-TNF-α). This study examined the difference between the two kinds of TNF-α in inducing cells and the relationship between the apoptosis induced by TM-TNF-α and the cell cycle. Bioassay was employed to compare the cytotoxic effect of two kinds of TNF-α on cell lines L-929 and HepG2. TUNEL was used to detect apoptosis and the TdT and PI co-staining were used for determining the phase of apoptotic cells. Our results showed that TM-TNF-α could kill not only s-TNF-sensitive L929 cells but also s-TNF-tolerant HepG2 cells. TM-TNF-α predominantly induced apoptosis while s-TNF could induce both apoptosis and necrosis. The apoptosis of L-929 cells induced by TM-TNF-α mainly occurred in S phase and the apoptosis of HepG2 predominantly took place in G₁ phase. It is concluded that the cytotoxic effects of the two TNF differ substantially. Since TM-TNF-α works locally, mainly induces apoptosis and has broader anti-tumor spectrum, it may be more effective for the treatment of tumor than s-TNF.

Keywords

transmembrane TNF-α / secretory TNF-α / apoptosis / cell cycle

References

[1] SzatmaryZ.. Tumor necrosis factor-alpha: molecular biological aspects minireview. Neoplasma, 1999, 46(5): 257-266

[2] KrieglerM., PerezC., DefayK., et al.. A novel form of TNFR cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell, 1988, 53(1): 45-253

[3] GrellM., DouniE., WajantH., et al.. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell, 1995, 83(5): 793-802

[4] ShiW. F., LiZ. Y., GongF. L., et al.. Comparison of the cyto-cidal effect induced by transmembrane and secreted TNF-alpha. Chin J Microbiol Immunol, 1998, 18(6): 499-504

[5] PeckR., BrockhausM., FreyJ. R., et al.. The principal tumor necrosis factor receptor in monocyte cytotoxicity is on the effector cell, not on the target cell. Cell Immunol, 1991, 132(2): 308-318

[6] LasterS. M., WoodJ. G., GoodingL. R.. Tumor necrosis fac-tor can induce both apoptic and necrotic forms of cell lysis. J Immunol, 1988, 141(8): 2629-2634

[7] TerlikowskiS. J.. Local immunotherapy with rhTNF-alpha mutein induces strong antitumor activity without overt toxicity—a review. Toxicology, 2002, 174(3): 143-152

[8] YoshimuraT., SoneS.. Different and synergistic actions of human tumor necrosis factor and interferon-gamma in damage of liposome membranes. J Biol Chem, 1987, 262(10): 4597-4601

[9] KullF. C., CuatrecasasP.. Possible requirement of inter-nalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum. Cancer Res, 1981, 41(12Pt1): 4885-4890

[10] HartwellL.H., KastanM.B.. Cell cycle control and cancer. Science, 1994, 266(5192): 1821-1828